Biogen
BIIB
#397
Rank
$41.95 B
Marketcap
$291.37
Share price
-0.18%
Change (1 day)
19.95%
Change (1 year)

Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.

Earnings for Biogen (BIIB)

Earnings in 2022 (TTM): $3.39 B

According to Biogen's latest financial reports the company's current earnings (TTM) are $3.39 B. In 2021 the company made an earning of $1.74 B a decrease over its 2020 earnings that were of $5.04 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Biogen from 2001 to 2022

Annual earnings

Year Earnings Change
2022 (TTM)$3.39 B94.42%
2021$1.74 B-65.43%
2020$5.04 B-29.17%
2019$7.12 B20.79%
2018$5.89 B15.03%
2017$5.12 B3.97%
2016$4.93 B3.48%
2015$4.76 B20.79%
2014$3.94 B59.1%
2013$2.48 B33.72%
2012$1.85 B8.41%
2011$1.71 B39.13%
2010$1.22 B-7.71%
2009$1.33 B15.99%
2008$1.14 B26.17%
2007$0.91 B85.02%
2006$0.49 B92.11%
2005$0.25 B299.73%
2004$64.09 M-107.28%
2003-$0.89 B-418.38%
2002$0.27 B-28.99%
2001$0.38 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
$22.51 B 563.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$34.92 B 929.27%๐Ÿ‡บ๐Ÿ‡ธ USA
$14.78 B 335.69%๐Ÿ‡บ๐Ÿ‡ธ USA
$7.72 B 127.79%๐Ÿ‡บ๐Ÿ‡ธ USA
$8.65 B 155.03%๐Ÿ‡ซ๐Ÿ‡ท France
$4.54 B 33.86%๐Ÿ‡บ๐Ÿ‡ธ USA
-$4.06 B-219.42%๐Ÿ‡บ๐Ÿ‡ธ USA
-$50.48 M-101.49%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.62 B-81.49%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
-$7.85 B-331.10%๐Ÿ‡บ๐Ÿ‡ธ USA